TWST
Twist Bioscience Corp
NASDAQ · Biotechnology
$49.24
+2.14 (+4.54%)
Performance
1D
—
1W
+5.19%
1M
+29.44%
3M
+57.22%
6M
+71.87%
1Y
+1.25%
YTD
+52.02%
Open$48.72
Previous Close$47.10
Day High$49.72
Day Low$47.00
52W High$54.74
52W Low$23.30
Volume2.06M
Avg Volume1.71M
Market Cap3.02B
P/E Ratio—
EPS$-1.27
SectorBiotechnology
Volume Analysis
1.21x average volume
Technical Indicators
SMA 50
$36.66
Above
SMA 200
$32.72
Above
RSI (14)
70.3
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
+45.4% upside
Current
$49.24
$49.24
Target
$71.60
$71.60
$49.68
$71.60 avg
$88.34
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 386.04M | 314.49M | 1.60B |
| Net Income | -79,625,501 | -58,381,222 | -268,607,823 |
| Profit Margin | -20.6% | -19.6% | -16.8% |
| EBITDA | -65,057,842 | -50,350,264 | -334,543,746 |
| Free Cash Flow | — | — | -300,671,350 |
| Rev Growth | +22.8% | +22.8% | +2.4% |
| Debt/Equity | — | — | 0.27 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |